Do breast cancer therapies increase the risk of myocardial infarction and stroke in women?
Breast cancer therapies are associated with cardiovascular toxicities such as myocardial infarction and stroke, highlighting the need for routine screening in breast cancer survivors.
The results supported the hypothesis about the toxic effect of BC therapies, suggesting that clinicians should routinely and actively screen for treatment-related toxicities in women with BC and that researchers should prioritize personalized treatments to minimize potentially devastating side effects.
Ricceri et al. (Thu,) studied this question.